Evidence map›Paper›PMID 30964439›Full record

ArticleJournal of medical Internet research2019

Addressing Diabetes and Poorly Controlled Hypertension: Pragmatic mHealth Self-Management Intervention.

Allison A Lewinski, Uptal D Patel, Clarissa J Diamantidis, Megan Oakes, Khaula Baloch, Matthew J Crowley, Jonathan Wilson, Jane Pendergast, Holly Biola, L Ebony Boulware and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02418091 (STOP-DKD Automated Population Program), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02418091 nacompletednot on this map

STOP-DKD Automated Population Program (APP)

TypeinterventionalSponsorDuke UniversityRan2015 to 2016Enrolled131ConditionsDiabetic Kidney Disease, Uncontrolled HypertensionArmsTelehealth
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Allison A Lewinski *Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, NC, United States.ORCID 0000-0002-1356-1857
Uptal D Patel *Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC, United States.ORCID 0000-0002-6905-6649
Clarissa J Diamantidis *Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, NC, United States.ORCID 0000-0001-8212-6288
Megan Oakes *Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States.ORCID 0000-0002-4619-1784
Khaula Baloch *Outcomes Research Group, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States.ORCID 0000-0003-2257-0234
Matthew J Crowley *Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, NC, United States.ORCID 0000-0002-6205-4536
Jonathan Wilson *Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States.ORCID 0000-0001-9984-4825
Jane Pendergast *Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, United States.ORCID 0000-0001-5169-8371
Holly Biola *Department of Family Medicine, Lincoln Community Health Center, Durham, NC, United States.ORCID 0000-0001-9884-1200
L Ebony Boulware *Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, United States.ORCID 0000-0002-8650-4212
Hayden B Bosworth *Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, NC, United States.ORCID 0000-0001-6188-9825
Duke University · USCommunity Health Center · USDurham VA Health Care System · US

Funding

Support for QA/QC for Prior Approval ProcessUL1TR002553 · NCATS · DUKE UNIVERSITY · PI LI, JENNIFER S, MCNAMARA, JAMES O. · 2018 to 2023
$58.5M
Renal Genomics CoreP30DK096493 · NIDDK · DUKE UNIVERSITY · PI GURLEY, SUSAN BAILEY · 2012 to 2016
$5.9M
Multi-factorial Intervention to Slow Progression of Diabetic Kidney DiseaseR01DK093938 · NIDDK · DUKE UNIVERSITY · PI BOSWORTH, HAYDEN B, DIAMANTIDIS, CLARISSA JONAS · 2013 to 2017
$3.4M
Integrated Population Program for Diabetic Kidney DiseaseR34DK102166 · NIDDK · DUKE UNIVERSITY · PI BOSWORTH, HAYDEN B, BOULWARE, LEIGH E · 2014 to 2015
$711k
Is there a digital divide in Chronic Kidney Disease (CKD)?K23DK099385 · NIDDK · DUKE UNIVERSITY · PI DIAMANTIDIS, CLARISSA JONAS · 2014 to 2017
$678k
HSRD VA CIN 13-410HSRD VA IK2 HX001514HSRD VA IK6 HX003161NCATS NIH HHS UL1 TR002553NIDDK NIH HHS K23 DK099385NIDDK NIH HHS P30 DK096493NIDDK NIH HHS R01 DK093938NIDDK NIH HHS R34 DK102166
6 · The paper itself

Abstract

backgroundPatients with diabetes and poorly controlled hypertension are at increased risk for adverse renal and cardiovascular outcomes. Identifying these patients early and addressing modifiable risk factors is central to delaying renal complications such as diabetic kidney disease. Mobile health (mHealth), a relatively inexpensive and easily scalable technology, can facilitate patient-centered care and promote engagement in self-management, particularly for patients of lower socioeconomic status. Thus, mHealth may be a cost-effective way to deliver self-management education and support.

objectiveThis feasibility study aimed to build a population management program by identifying patients with diabetes and poorly controlled hypertension who were at risk for adverse renal outcomes and evaluate a multifactorial intervention to address medication self-management. We recruited patients from a federally qualified health center (FQHC) in an underserved, diverse county in the southeastern United States.

methodsPatients were identified via electronic health record. Inclusion criteria were age between 18 and 75 years, diagnosis of type 2 diabetes, poorly controlled hypertension over the last 12 months (mean clinic systolic blood pressure [SBP] ≥140 mm Hg and/or diastolic blood pressure [DBP] ≥90 mm Hg), access to a mobile phone, and ability to receive text messages and emails. The intervention consisted of monthly telephone calls for 6 months by a case manager and weekly, one-way informational text messages. Engagement was defined as the number of phone calls completed during the intervention; individuals who completed 4 or more calls were considered engaged. The primary outcome was change in SBP at the conclusion of the intervention.

resultsOf the 141 patients enrolled, 84.0% (118/141) of patients completed 1 or more phone calls and had follow-up SBP measurements for analysis. These patients were on average 56.9 years of age, predominately female (73/118, 61.9%), and nonwhite by self-report (103/118, 87.3%). The proportion of participants with poor baseline SBP control (50/118, 42.4%) did not change significantly at study completion (53/118, 44.9%) (P=.64). Participants who completed 4 or more phone calls (98/118, 83.1%) did not experience a statistically significant decrease in SBP when compared to those who completed fewer calls.

conclusionWe did not reduce uncontrolled hypertension even among the more highly engaged. However, 83% of a predominately minority and low-income population completed at least 67% of the multimodal mHealth intervention. Findings suggest that combining an automated electronic health record system to identify at-risk patients with a tailored mHealth protocol can provide education to this population. While this intervention was insufficient to effect behavioral change resulting in better hypertension control, it does suggest that this FQHC population will engage in low-cost population health applications with a potentially promising impact.

trial registrationClinicalTrials.gov NCT02418091; https://clinicaltrials.gov/ct2/show/NCT02418091 (Archived by WebCite at http://www.webcitation.org/76RBvacVU).

Indexed as

Diabetes Mellitus, Type 2Feasibility StudiesFemaleHumansHypertensionMiddle AgedSelf-ManagementTelemedicinecardiovascular diseasesdiabetes mellitus type 2hypertensionprofessional-patient relationsrenal insufficiencytelemedicinevulnerable populations

Identifiers

PMID30964439
PMCPMC6477575
OpenAlexW2939469867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.